Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.

Feng GaoKenneth I ZhengXiao-Bo WangHua-Dong YanQing-Feng SunKe-Hua PanTing-Yao WangYong-Ping ChenJacob GeorgeMing-Hua Zheng

Published in: Journal of gastroenterology and hepatology (2020)

Health-care professionals caring for nondiabetic patients with COVID-19 should be cognizant of the increased likelihood of severe COVID-19 in patients with MAFLD.

Keyphrases

coronavirus disease
healthcare
end stage renal disease
ejection fraction
newly diagnosed
sars cov
chronic kidney disease
prognostic factors
patient reported outcomes
fatty acid
social media